The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4+Foxp3+CD25−T cells in patients with leukemic cutaneous T-cell lymphoma-Reference-Cited by-同舟云学术

The effect of extracorporeal photopheresis alone or in combination therapy on circulating CD4+Foxp3+CD25−T cells in patients with leukemic cutaneous T-cell lymphoma

Published:2015-03-28 Issue:4 Volume:31 Page:184-194
ISSN:0905-4383
Container-title:Photodermatology, Photoimmunology & Photomedicine
language:en
Short-container-title:Photodermatol. Photoimmunol. Photomed.

Author:

Shiue Lisa H.¹²,Couturier Jacob³⁴,Lewis Dorothy E.³⁴,Wei Caimiao⁵,Ni Xiao¹²,Duvic Madeleine¹²

Affiliation:

1. Department of Dermatology; The University of Texas MD Anderson Cancer Center; Houston TX USA

2. Graduate Program in Immunology; Graduate School of Biomedical Sciences; University of Texas Health Science Center at Houston; Houston TX USA

3. Department of Internal Medicine; University of Texas Health Science Center at Houston; Houston TX USA

4. Graduate Program in Virology; Graduate School of Biomedical Sciences; University of Texas Health Science Center at Houston; Houston TX USA

5. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston TX USA

Funder

CCTS T32 Pre-doctoral Training Program

Investigator-initiated research grant from Therakos, Inc.

Mr. and Mrs. R. John Stanton, Jr. CTCL Research Fund

Publisher

Wiley

Subject

Dermatology,Radiology, Nuclear Medicine and imaging,Immunology,General Medicine,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/phpp.12175/fullpdf

Reference49 articles.

1. WHO-EORTC classification for cutaneous lymphomas;Willemze;Blood,2005

2. Prognostic significance of tumor burden in the blood of patients with erythrodermic primary cutaneous T-cell lymphoma;Scarisbrick;Blood,2001

3. Overall survival in erythrodermic cutaneous T-cell lymphoma: an analysis of prognostic factors in a cohort of patients with erythrodermic cutaneous T-cell lymphoma;Vidulich;Int J Dermatol,2009

4. Talpur RDS Seyfer S Liu P Duvic M Long-term outcomes of 1263 patients with mycosis fungoides and Sezary syndrome from 1982-2009

5. Total skin electron beam and non-myeloablative allogeneic hematopoietic stem-cell transplantation in advanced mycosis fungoides and Sezary syndrome;Duvic;J Clin Oncol,2010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. What Does the Future Hold for Biomarkers of Response to Extracorporeal Photopheresis for Mycosis Fungoides and Sézary Syndrome?;Cells;2023-09-20

2. The Microenvironment’s Role in Mycosis Fungoides and Sézary Syndrome: From Progression to Therapeutic Implications;Cells;2021-10-17

3. Monitoring malignant T‐cell clones by direct TCR expression assay in patients with leukemic cutaneous T‐cell lymphoma during extracorporeal photopheresis;Photodermatology, Photoimmunology & Photomedicine;2021-09-26

4. Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives;Frontiers in Oncology;2021-08-16

5. European dermatology forum – updated guidelines on the use of extracorporeal photopheresis 2020 – part 1;Journal of the European Academy of Dermatology and Venereology;2020-10-06